318 results
Page 7 of 16
DEF 14A
76otc5 pmqv6wmau0ct
28 Apr 16
Definitive proxy
8:00pm
10-K
a5ukgzf
13 Apr 16
Annual report
8:00pm
10-K
EX-10.34
k79fkda2
13 Apr 16
Annual report
8:00pm
D
958xf24w
19 Jan 16
$2.2M in equity / options, sold $2.2M, 5 investors
7:00pm
8-K
EX-10.2
ttp7omu8
10 Jan 16
Transgenomic Announces Conversion of Series a and B Preferred Securities and Extension of Loan Maturity Date
7:00pm
8-K
EX-10.1
8hguzthrzc2oox1jj
10 Jan 16
Transgenomic Announces Private Placement Financing
7:00pm
8-K
zglwgn37e1815j49
30 Nov 15
Transgenomic Finalizes Divestment of Its Genetic Assays & Platforms
7:00pm
10-Q
dcpgixb3zk2vjgc
15 Nov 15
Quarterly report
7:00pm
10-Q
EX-10.2
v7sph
15 Nov 15
Quarterly report
7:00pm
10-Q
EX-10.3
mc5vjjh ulqu9b9
15 Nov 15
Quarterly report
7:00pm
10-K/A
xz2 on8t71ua
20 Aug 15
Annual report (amended)
8:00pm
10-Q
zqmvp88kbb ye4jc
13 Aug 15
Quarterly report
8:00pm
D
dyi57yys cwsi
16 Jul 15
$3.04M in equity / options, sold $3.04M, 2 investors
8:00pm
8-K/A
EX-10.1
9zq j0awl2xpv
6 Jul 15
Entry into a Material Definitive Agreement
8:00pm
10-Q
nv3olucdlr87b
13 May 15
Quarterly report
8:00pm
DEF 14A
mi5gyq0g
29 Apr 15
Definitive proxy
8:00pm
10-K
9cb5nivhdhdkj
14 Apr 15
Annual report
8:00pm
424B5
avu87f063d
26 Feb 15
Prospectus supplement for primary offering
7:00pm
8-K
EX-1.1
f49ndi6qwc4dad0hi
26 Feb 15
Transgenomic Announces Commencement of Public Offering of Common Stock
7:00pm
424B5
9i34glwkp0mm
25 Feb 15
Prospectus supplement for primary offering
7:00pm